跳至主要内容
临床试验/NCT02698592
NCT02698592Unknown4 期

Comparative Study to Assess Safety and Efficacy of Catheters CelsiusTMDS® 8 mm, Thermocool® 3.5 mm of Irrigated Tip and Thermocool® SF in the Treatment of Cavo-tricuspid Isthmus Dependent Atrial Flutter

Hospital Universitario Central de Asturias2 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2012年1月最近更新:
适应症

试验速览

阶段
4 期
入组人数
150
试验地点
2
主要终点
Time to get cavo-tricuspid isthmus block

研究概览

简要总结

The purpose of this study is to determine whether the Thermocool SF ® system is at least as effective and safe as regular 8mm catheters and irrigated tip catheters in the treatment of cavo-tricuspid isthmus dependent atrial flutter.

详细描述

The catheter of Biosense Webster Thermocool SF® is characterized by a porous, thin-walled tip allowing a uniform cooling of the catheter tip and so, achieving increased efficiency in cooling. This allows to reduce the flow of irrigation and power output while achieving similar tissue temperatures as the conventional irrigated catheters. There is evidence of greater efficiency of Thermocool SF® catheter in causing tissue damage, but there are no clinical studies on the specific treatment of common atrial flutter.

Investigators hypothesize that the Thermocool SF® system is at least as effective and safe in the treatment of cavo-tricuspid isthmus dependent atrial flutter as conventional and 8 mm irrigated tip catheters.

150 patients with common atrial flutter were randomized to 3 groups of 50 patients and each group underwent ablation catheter ablation with CelsiusTMDS® 8 mm, 3.5 mm irrigated tip Thermocool® or Thermocool® SF respectively. After the procedure, patients are being followed by clinical reviews, electrocardiograms at the 3rd, 6th and 12th months, 24h ECG-Holter examination at the first and 6th month and monthly phone consultation. Rate of recurrence and presence of other supraventricular arrhythmias are being recorded during follow-up.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with symptomatic common atrial flutter.
  • Electrocardiographic documentation of common atrial flutter.

排除标准

  • Refusal to give consent.
  • Life expectancy less than 6 months.
  • Contraindication for ablation.
  • Previous cavo-tricuspid isthmus ablation.

结局指标

主要结局

Time to get cavo-tricuspid isthmus block

时间窗: during the ablation.

次要结局

  • Time of fluoroscopy.(during the ablation.)
  • Radio frequency application time.(during the ablation.)
  • Complications.(within the first 24 hours.)
  • Recurrence of atrial flutter.(one year.)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Evaluation of Thermocool SF Catheter on the Common... | 临床试验